nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—NR3C1—type 2 diabetes mellitus	0.667	1	CbGaD
Fluocinonide—Eruption—Tolbutamide—type 2 diabetes mellitus	0.00649	0.0353	CcSEcCtD
Fluocinonide—Eruption—Chlorpropamide—type 2 diabetes mellitus	0.0059	0.0321	CcSEcCtD
Fluocinonide—Eruption—Tolazamide—type 2 diabetes mellitus	0.0059	0.0321	CcSEcCtD
Fluocinonide—Eruption—Glipizide—type 2 diabetes mellitus	0.00392	0.0213	CcSEcCtD
Fluocinonide—Eruption—Glimepiride—type 2 diabetes mellitus	0.00366	0.0199	CcSEcCtD
Fluocinonide—Skin exfoliation—Linagliptin—type 2 diabetes mellitus	0.00343	0.0187	CcSEcCtD
Fluocinonide—Eruption—Glyburide—type 2 diabetes mellitus	0.00301	0.0164	CcSEcCtD
Fluocinonide—Glycosuria—Pioglitazone—type 2 diabetes mellitus	0.00285	0.0155	CcSEcCtD
Fluocinonide—SMO—cortex of kidney—type 2 diabetes mellitus	0.00257	0.135	CbGeAlD
Fluocinonide—SMO—adipose tissue—type 2 diabetes mellitus	0.00238	0.125	CbGeAlD
Fluocinonide—Nasopharyngitis—Linagliptin—type 2 diabetes mellitus	0.00233	0.0127	CcSEcCtD
Fluocinonide—Glycosuria—Gliclazide—type 2 diabetes mellitus	0.00206	0.0112	CcSEcCtD
Fluocinonide—NR3C1—nerve—type 2 diabetes mellitus	0.00186	0.0975	CbGeAlD
Fluocinonide—Nasopharyngitis—Rosiglitazone—type 2 diabetes mellitus	0.00179	0.00972	CcSEcCtD
Fluocinonide—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00174	0.0095	CcSEcCtD
Fluocinonide—SMO—liver—type 2 diabetes mellitus	0.00167	0.0875	CbGeAlD
Fluocinonide—SERPINA6—nephron tubule—type 2 diabetes mellitus	0.00165	0.0868	CbGeAlD
Fluocinonide—Hyperglycaemia—Repaglinide—type 2 diabetes mellitus	0.00165	0.00897	CcSEcCtD
Fluocinonide—Immune system disorder—Linagliptin—type 2 diabetes mellitus	0.00163	0.00887	CcSEcCtD
Fluocinonide—Glycosuria—Irbesartan—type 2 diabetes mellitus	0.00162	0.00883	CcSEcCtD
Fluocinonide—Nasal congestion—Bromocriptine—type 2 diabetes mellitus	0.00162	0.0088	CcSEcCtD
Fluocinonide—Erythema—Tolazamide—type 2 diabetes mellitus	0.00159	0.00864	CcSEcCtD
Fluocinonide—Immune system disorder—Acarbose—type 2 diabetes mellitus	0.00158	0.00861	CcSEcCtD
Fluocinonide—Hyperglycaemia—Rosiglitazone—type 2 diabetes mellitus	0.00156	0.00848	CcSEcCtD
Fluocinonide—Glycosuria—Losartan—type 2 diabetes mellitus	0.00153	0.00831	CcSEcCtD
Fluocinonide—Immune system disorder—Nateglinide—type 2 diabetes mellitus	0.00153	0.00831	CcSEcCtD
Fluocinonide—Erythema—Acarbose—type 2 diabetes mellitus	0.00153	0.0083	CcSEcCtD
Fluocinonide—Nasopharyngitis—Sitagliptin—type 2 diabetes mellitus	0.00145	0.00792	CcSEcCtD
Fluocinonide—SERPINA6—kidney—type 2 diabetes mellitus	0.00145	0.0763	CbGeAlD
Fluocinonide—SERPINA6—cortex of kidney—type 2 diabetes mellitus	0.00141	0.0743	CbGeAlD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00133	0.00723	CcSEcCtD
Fluocinonide—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.00132	0.00719	CcSEcCtD
Fluocinonide—Nasopharyngitis—Bromocriptine—type 2 diabetes mellitus	0.00132	0.00717	CcSEcCtD
Fluocinonide—Hyperglycaemia—Pioglitazone—type 2 diabetes mellitus	0.00131	0.00711	CcSEcCtD
Fluocinonide—Infection—Linagliptin—type 2 diabetes mellitus	0.00127	0.00693	CcSEcCtD
Fluocinonide—Erythema—Repaglinide—type 2 diabetes mellitus	0.00127	0.00693	CcSEcCtD
Fluocinonide—Hyperglycaemia—Sitagliptin—type 2 diabetes mellitus	0.00127	0.0069	CcSEcCtD
Fluocinonide—Swelling—Valsartan—type 2 diabetes mellitus	0.00126	0.00685	CcSEcCtD
Fluocinonide—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00125	0.0068	CcSEcCtD
Fluocinonide—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00125	0.00678	CcSEcCtD
Fluocinonide—Skin exfoliation—Losartan—type 2 diabetes mellitus	0.00118	0.00643	CcSEcCtD
Fluocinonide—Nasal congestion—Metformin—type 2 diabetes mellitus	0.00111	0.00604	CcSEcCtD
Fluocinonide—Dry skin—Gliclazide—type 2 diabetes mellitus	0.00111	0.00603	CcSEcCtD
Fluocinonide—Swelling—Irbesartan—type 2 diabetes mellitus	0.00108	0.00589	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00108	0.00586	CcSEcCtD
Fluocinonide—Erythema—Glipizide—type 2 diabetes mellitus	0.00105	0.00573	CcSEcCtD
Fluocinonide—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.00105	0.0057	CcSEcCtD
Fluocinonide—Swelling—Losartan—type 2 diabetes mellitus	0.00102	0.00554	CcSEcCtD
Fluocinonide—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.00102	0.00553	CcSEcCtD
Fluocinonide—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00101	0.00549	CcSEcCtD
Fluocinonide—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00101	0.00548	CcSEcCtD
Fluocinonide—Dry skin—Orlistat—type 2 diabetes mellitus	0.00101	0.00547	CcSEcCtD
Fluocinonide—Rash—Miglitol—type 2 diabetes mellitus	0.000999	0.00544	CcSEcCtD
Fluocinonide—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000998	0.00543	CcSEcCtD
Fluocinonide—Nasal congestion—Losartan—type 2 diabetes mellitus	0.000986	0.00537	CcSEcCtD
Fluocinonide—Erythema—Glimepiride—type 2 diabetes mellitus	0.000983	0.00535	CcSEcCtD
Fluocinonide—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000975	0.00531	CcSEcCtD
Fluocinonide—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.000963	0.00524	CcSEcCtD
Fluocinonide—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000945	0.00514	CcSEcCtD
Fluocinonide—Hyperglycaemia—Gliclazide—type 2 diabetes mellitus	0.000942	0.00513	CcSEcCtD
Fluocinonide—SERPINA6—liver—type 2 diabetes mellitus	0.000918	0.0482	CbGeAlD
Fluocinonide—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000917	0.00499	CcSEcCtD
Fluocinonide—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000917	0.00499	CcSEcCtD
Fluocinonide—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000917	0.00499	CcSEcCtD
Fluocinonide—Nasopharyngitis—Metformin—type 2 diabetes mellitus	0.000904	0.00492	CcSEcCtD
Fluocinonide—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000899	0.0472	CbGeAlD
Fluocinonide—Rash—Tolbutamide—type 2 diabetes mellitus	0.000898	0.00489	CcSEcCtD
Fluocinonide—Headache—Tolbutamide—type 2 diabetes mellitus	0.000892	0.00486	CcSEcCtD
Fluocinonide—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000884	0.00481	CcSEcCtD
Fluocinonide—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000857	0.00466	CcSEcCtD
Fluocinonide—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000857	0.00466	CcSEcCtD
Fluocinonide—Nasopharyngitis—Irbesartan—type 2 diabetes mellitus	0.000853	0.00464	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000853	0.00464	CcSEcCtD
Fluocinonide—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000849	0.00462	CcSEcCtD
Fluocinonide—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.000845	0.0046	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000828	0.00451	CcSEcCtD
Fluocinonide—Dry skin—Losartan—type 2 diabetes mellitus	0.000823	0.00448	CcSEcCtD
Fluocinonide—Infection—Pioglitazone—type 2 diabetes mellitus	0.000818	0.00445	CcSEcCtD
Fluocinonide—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000817	0.00445	CcSEcCtD
Fluocinonide—Rash—Tolazamide—type 2 diabetes mellitus	0.000817	0.00445	CcSEcCtD
Fluocinonide—Headache—Tolazamide—type 2 diabetes mellitus	0.000812	0.00442	CcSEcCtD
Fluocinonide—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000812	0.00442	CcSEcCtD
Fluocinonide—Erythema—Glyburide—type 2 diabetes mellitus	0.000811	0.00441	CcSEcCtD
Fluocinonide—Rash—Linagliptin—type 2 diabetes mellitus	0.000808	0.0044	CcSEcCtD
Fluocinonide—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000808	0.0044	CcSEcCtD
Fluocinonide—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000808	0.0044	CcSEcCtD
Fluocinonide—Headache—Linagliptin—type 2 diabetes mellitus	0.000803	0.00437	CcSEcCtD
Fluocinonide—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.0008	0.00435	CcSEcCtD
Fluocinonide—Infection—Sitagliptin—type 2 diabetes mellitus	0.000794	0.00432	CcSEcCtD
Fluocinonide—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000794	0.00432	CcSEcCtD
Fluocinonide—Rash—Acarbose—type 2 diabetes mellitus	0.000785	0.00427	CcSEcCtD
Fluocinonide—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000784	0.00427	CcSEcCtD
Fluocinonide—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000784	0.00427	CcSEcCtD
Fluocinonide—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000777	0.00423	CcSEcCtD
Fluocinonide—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000765	0.00417	CcSEcCtD
Fluocinonide—Rash—Nateglinide—type 2 diabetes mellitus	0.000757	0.00412	CcSEcCtD
Fluocinonide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000756	0.00412	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00075	0.00408	CcSEcCtD
Fluocinonide—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000744	0.00405	CcSEcCtD
Fluocinonide—Pain—Glipizide—type 2 diabetes mellitus	0.000735	0.004	CcSEcCtD
Fluocinonide—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000735	0.004	CcSEcCtD
Fluocinonide—Erythema—Gliclazide—type 2 diabetes mellitus	0.000728	0.00396	CcSEcCtD
Fluocinonide—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000724	0.038	CbGeAlD
Fluocinonide—Infection—Bromocriptine—type 2 diabetes mellitus	0.000719	0.00391	CcSEcCtD
Fluocinonide—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00071	0.00386	CcSEcCtD
Fluocinonide—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000703	0.00383	CcSEcCtD
Fluocinonide—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.0007	0.00381	CcSEcCtD
Fluocinonide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000695	0.00378	CcSEcCtD
Fluocinonide—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000694	0.00378	CcSEcCtD
Fluocinonide—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000686	0.00373	CcSEcCtD
Fluocinonide—Pain—Sitagliptin—type 2 diabetes mellitus	0.000684	0.00372	CcSEcCtD
Fluocinonide—Rash—Repaglinide—type 2 diabetes mellitus	0.000655	0.00357	CcSEcCtD
Fluocinonide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000654	0.00356	CcSEcCtD
Fluocinonide—Headache—Repaglinide—type 2 diabetes mellitus	0.000651	0.00354	CcSEcCtD
Fluocinonide—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.00065	0.0341	CbGeAlD
Fluocinonide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000649	0.00353	CcSEcCtD
Fluocinonide—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000649	0.00353	CcSEcCtD
Fluocinonide—NR3C1—kidney—type 2 diabetes mellitus	0.000636	0.0334	CbGeAlD
Fluocinonide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000633	0.00345	CcSEcCtD
Fluocinonide—NR3C1—pancreas—type 2 diabetes mellitus	0.000632	0.0332	CbGeAlD
Fluocinonide—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000632	0.00344	CcSEcCtD
Fluocinonide—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.00062	0.0325	CbGeAlD
Fluocinonide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000619	0.00337	CcSEcCtD
Fluocinonide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000619	0.00337	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000615	0.00335	CcSEcCtD
Fluocinonide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000615	0.00335	CcSEcCtD
Fluocinonide—Erythema—Metformin—type 2 diabetes mellitus	0.000609	0.00331	CcSEcCtD
Fluocinonide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000608	0.00331	CcSEcCtD
Fluocinonide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000607	0.0033	CcSEcCtD
Fluocinonide—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000596	0.00325	CcSEcCtD
Fluocinonide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000591	0.00322	CcSEcCtD
Fluocinonide—Infection—Gliclazide—type 2 diabetes mellitus	0.00059	0.00321	CcSEcCtD
Fluocinonide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000589	0.00321	CcSEcCtD
Fluocinonide—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000583	0.00317	CcSEcCtD
Fluocinonide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000577	0.00314	CcSEcCtD
Fluocinonide—Erythema—Irbesartan—type 2 diabetes mellitus	0.000575	0.00313	CcSEcCtD
Fluocinonide—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000573	0.0301	CbGeAlD
Fluocinonide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000568	0.00309	CcSEcCtD
Fluocinonide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000567	0.00309	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000565	0.00308	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000559	0.00304	CcSEcCtD
Fluocinonide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000545	0.00296	CcSEcCtD
Fluocinonide—Infection—Valsartan—type 2 diabetes mellitus	0.000542	0.00295	CcSEcCtD
Fluocinonide—Rash—Glipizide—type 2 diabetes mellitus	0.000542	0.00295	CcSEcCtD
Fluocinonide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000541	0.00295	CcSEcCtD
Fluocinonide—Erythema—Losartan—type 2 diabetes mellitus	0.000541	0.00294	CcSEcCtD
Fluocinonide—Headache—Glipizide—type 2 diabetes mellitus	0.000538	0.00293	CcSEcCtD
Fluocinonide—Infection—Orlistat—type 2 diabetes mellitus	0.000536	0.00292	CcSEcCtD
Fluocinonide—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000535	0.00291	CcSEcCtD
Fluocinonide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00053	0.00289	CcSEcCtD
Fluocinonide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00053	0.00289	CcSEcCtD
Fluocinonide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000529	0.00288	CcSEcCtD
Fluocinonide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000529	0.00288	CcSEcCtD
Fluocinonide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000524	0.00285	CcSEcCtD
Fluocinonide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000516	0.00281	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000515	0.0028	CcSEcCtD
Fluocinonide—Pain—Gliclazide—type 2 diabetes mellitus	0.000508	0.00276	CcSEcCtD
Fluocinonide—Rash—Glimepiride—type 2 diabetes mellitus	0.000506	0.00275	CcSEcCtD
Fluocinonide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000505	0.00275	CcSEcCtD
Fluocinonide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000504	0.00274	CcSEcCtD
Fluocinonide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000504	0.00274	CcSEcCtD
Fluocinonide—Headache—Glimepiride—type 2 diabetes mellitus	0.000503	0.00274	CcSEcCtD
Fluocinonide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000501	0.00273	CcSEcCtD
Fluocinonide—Infection—Metformin—type 2 diabetes mellitus	0.000494	0.00269	CcSEcCtD
Fluocinonide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000487	0.00265	CcSEcCtD
Fluocinonide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000487	0.00265	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000486	0.00264	CcSEcCtD
Fluocinonide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000483	0.00263	CcSEcCtD
Fluocinonide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000481	0.00262	CcSEcCtD
Fluocinonide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000479	0.0026	CcSEcCtD
Fluocinonide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000468	0.00255	CcSEcCtD
Fluocinonide—Infection—Irbesartan—type 2 diabetes mellitus	0.000466	0.00254	CcSEcCtD
Fluocinonide—Erythema—Ramipril—type 2 diabetes mellitus	0.000464	0.00252	CcSEcCtD
Fluocinonide—Pain—Orlistat—type 2 diabetes mellitus	0.000461	0.00251	CcSEcCtD
Fluocinonide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00046	0.0025	CcSEcCtD
Fluocinonide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000456	0.00248	CcSEcCtD
Fluocinonide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000456	0.00248	CcSEcCtD
Fluocinonide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000456	0.00248	CcSEcCtD
Fluocinonide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000453	0.00247	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000444	0.00367	CbGpPWpGaD
Fluocinonide—Infection—Losartan—type 2 diabetes mellitus	0.000438	0.00239	CcSEcCtD
Fluocinonide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000438	0.00238	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000435	0.0036	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.000434	0.00359	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000433	0.00236	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.000429	0.00355	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000426	0.00353	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000422	0.00349	CbGpPWpGaD
Fluocinonide—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000421	0.0444	CrCbGaD
Fluocinonide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00042	0.00229	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.000419	0.00347	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.000417	0.00345	CbGpPWpGaD
Fluocinonide—Rash—Glyburide—type 2 diabetes mellitus	0.000417	0.00227	CcSEcCtD
Fluocinonide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000417	0.00227	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.000417	0.00345	CbGpPWpGaD
Fluocinonide—Headache—Glyburide—type 2 diabetes mellitus	0.000414	0.00226	CcSEcCtD
Fluocinonide—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000408	0.043	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000404	0.00334	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000403	0.00333	CbGpPWpGaD
Fluocinonide—NR3C1—liver—type 2 diabetes mellitus	0.000402	0.0211	CbGeAlD
Fluocinonide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000402	0.00219	CcSEcCtD
Fluocinonide—Pain—Irbesartan—type 2 diabetes mellitus	0.000401	0.00218	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.000399	0.0033	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000397	0.00216	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000397	0.00328	CbGpPWpGaD
Fluocinonide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000393	0.00214	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000392	0.00213	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.000387	0.00321	CbGpPWpGaD
Fluocinonide—Desonide—NR3C1—type 2 diabetes mellitus	0.000386	0.0407	CrCbGaD
Fluocinonide—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000386	0.0407	CrCbGaD
Fluocinonide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000386	0.0021	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000386	0.00319	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.000386	0.00319	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.000386	0.00319	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000385	0.00318	CbGpPWpGaD
Fluocinonide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000382	0.00208	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000381	0.00315	CbGpPWpGaD
Fluocinonide—Pain—Losartan—type 2 diabetes mellitus	0.000377	0.00205	CcSEcCtD
Fluocinonide—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000377	0.0397	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.000377	0.00312	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000376	0.00311	CbGpPWpGaD
Fluocinonide—Rash—Gliclazide—type 2 diabetes mellitus	0.000375	0.00204	CcSEcCtD
Fluocinonide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000374	0.00204	CcSEcCtD
Fluocinonide—Headache—Gliclazide—type 2 diabetes mellitus	0.000372	0.00203	CcSEcCtD
Fluocinonide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000371	0.00202	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.000369	0.00305	CbGpPWpGaD
Fluocinonide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000368	0.002	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.000367	0.00304	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000363	0.003	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000363	0.003	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000362	0.003	CbGpPWpGaD
Fluocinonide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000361	0.00196	CcSEcCtD
Fluocinonide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000357	0.00194	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000356	0.00295	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000353	0.00292	CbGpPWpGaD
Fluocinonide—Pruritus—Metformin—type 2 diabetes mellitus	0.000352	0.00191	CcSEcCtD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000348	0.00288	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000346	0.00188	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000345	0.00285	CbGpPWpGaD
Fluocinonide—Rash—Valsartan—type 2 diabetes mellitus	0.000344	0.00187	CcSEcCtD
Fluocinonide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000344	0.00187	CcSEcCtD
Fluocinonide—Headache—Valsartan—type 2 diabetes mellitus	0.000342	0.00186	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000341	0.00282	CbGpPWpGaD
Fluocinonide—Rash—Orlistat—type 2 diabetes mellitus	0.00034	0.00185	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.00034	0.00281	CbGpPWpGaD
Fluocinonide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00034	0.00185	CcSEcCtD
Fluocinonide—Headache—Orlistat—type 2 diabetes mellitus	0.000338	0.00184	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000336	0.00278	CbGpPWpGaD
Fluocinonide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000332	0.00181	CcSEcCtD
Fluocinonide—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.00033	0.0348	CrCbGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.00033	0.00273	CbGpPWpGaD
Fluocinonide—Dizziness—Metformin—type 2 diabetes mellitus	0.000329	0.00179	CcSEcCtD
Fluocinonide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000325	0.00177	CcSEcCtD
Fluocinonide—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000324	0.0342	CrCbGaD
Fluocinonide—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000319	0.0336	CrCbGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.000317	0.00263	CbGpPWpGaD
Fluocinonide—Rash—Metformin—type 2 diabetes mellitus	0.000313	0.00171	CcSEcCtD
Fluocinonide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000313	0.0017	CcSEcCtD
Fluocinonide—Pruritus—Losartan—type 2 diabetes mellitus	0.000312	0.0017	CcSEcCtD
Fluocinonide—Headache—Metformin—type 2 diabetes mellitus	0.000311	0.00169	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000311	0.00257	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.00031	0.00257	CbGpPWpGaD
Fluocinonide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00031	0.00169	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000302	0.0025	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.000301	0.00249	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.000301	0.00249	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000299	0.00247	CbGpPWpGaD
Fluocinonide—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000297	0.0313	CrCbGaD
Fluocinonide—Budesonide—NR3C1—type 2 diabetes mellitus	0.000297	0.0313	CrCbGaD
Fluocinonide—Rash—Irbesartan—type 2 diabetes mellitus	0.000296	0.00161	CcSEcCtD
Fluocinonide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000295	0.00161	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000295	0.00244	CbGpPWpGaD
Fluocinonide—Headache—Irbesartan—type 2 diabetes mellitus	0.000294	0.0016	CcSEcCtD
Fluocinonide—Dizziness—Losartan—type 2 diabetes mellitus	0.000292	0.00159	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000291	0.00241	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000291	0.0307	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000289	0.0024	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000289	0.00239	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000287	0.00237	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000286	0.00236	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.000284	0.00235	CbGpPWpGaD
Fluocinonide—Mometasone—NR3C1—type 2 diabetes mellitus	0.000282	0.0297	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000279	0.00231	CbGpPWpGaD
Fluocinonide—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000279	0.0294	CrCbGaD
Fluocinonide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000279	0.00152	CcSEcCtD
Fluocinonide—Rash—Losartan—type 2 diabetes mellitus	0.000278	0.00151	CcSEcCtD
Fluocinonide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000278	0.00151	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000277	0.00229	CbGpPWpGaD
Fluocinonide—Headache—Losartan—type 2 diabetes mellitus	0.000277	0.00151	CcSEcCtD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000276	0.00228	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000274	0.00227	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000273	0.00226	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000272	0.00225	CbGpPWpGaD
Fluocinonide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000268	0.00146	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000265	0.00219	CbGpPWpGaD
Fluocinonide—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000263	0.0277	CrCbGaD
Fluocinonide—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.00026	0.00215	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000257	0.00212	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000256	0.00212	CbGpPWpGaD
Fluocinonide—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000256	0.0269	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000255	0.00211	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000251	0.00208	CbGpPWpGaD
Fluocinonide—Dizziness—Ramipril—type 2 diabetes mellitus	0.00025	0.00136	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00025	0.00207	CbGpPWpGaD
Fluocinonide—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000249	0.0262	CrCbGaD
Fluocinonide—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000249	0.0262	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000249	0.00206	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000249	0.00206	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000248	0.00205	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000248	0.00205	CbGpPWpGaD
Fluocinonide—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000246	0.0259	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000245	0.00202	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000243	0.00201	CbGpPWpGaD
Fluocinonide—Ciclesonide—NR3C1—type 2 diabetes mellitus	0.000242	0.0255	CrCbGaD
Fluocinonide—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.00024	0.0253	CrCbGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000239	0.00198	CbGpPWpGaD
Fluocinonide—Rash—Ramipril—type 2 diabetes mellitus	0.000239	0.0013	CcSEcCtD
Fluocinonide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000238	0.0013	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000238	0.00197	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000237	0.00196	CbGpPWpGaD
Fluocinonide—Headache—Ramipril—type 2 diabetes mellitus	0.000237	0.00129	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000232	0.00192	CbGpPWpGaD
Fluocinonide—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000232	0.0244	CrCbGaD
Fluocinonide—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000231	0.00191	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000229	0.00189	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000228	0.00189	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000228	0.00189	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000225	0.00187	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000225	0.00186	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000224	0.00186	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000222	0.0234	CrCbGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000221	0.00183	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.00022	0.00182	CbGpPWpGaD
Fluocinonide—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000218	0.023	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000215	0.00178	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000214	0.00177	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000213	0.00177	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000209	0.00173	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000208	0.00173	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000205	0.00169	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000204	0.00169	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000204	0.00168	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000201	0.00166	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000201	0.00166	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000199	0.00165	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000199	0.00165	CbGpPWpGaD
Fluocinonide—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000196	0.0206	CrCbGaD
Fluocinonide—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000194	0.00161	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000193	0.0016	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000191	0.00158	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000189	0.00157	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000188	0.00156	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000186	0.00154	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000186	0.00154	CbGpPWpGaD
Fluocinonide—Dexamethasone—NOS2—type 2 diabetes mellitus	0.000184	0.0194	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000182	0.00151	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000179	0.00148	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000178	0.00147	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000178	0.00147	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000177	0.00147	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000177	0.00146	CbGpPWpGaD
Fluocinonide—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	0.000175	0.0184	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000172	0.00143	CbGpPWpGaD
Fluocinonide—Budesonide—CYP3A4—type 2 diabetes mellitus	0.000172	0.0181	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000171	0.00141	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.00017	0.0014	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.00017	0.0014	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	0.000169	0.0178	CrCbGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000168	0.00139	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000168	0.00139	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000168	0.00139	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000165	0.00137	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000165	0.00136	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	0.000161	0.00133	CbGpPWpGaD
Fluocinonide—Betamethasone—NR3C1—type 2 diabetes mellitus	0.00016	0.0169	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	0.000159	0.00132	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	0.000156	0.00129	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000152	0.00126	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	0.000152	0.00125	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	0.000151	0.00125	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	0.000151	0.00125	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	0.000151	0.00125	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000151	0.00125	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000151	0.00125	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000149	0.00123	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000148	0.00123	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	0.000148	0.00123	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000147	0.00122	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000147	0.00122	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000147	0.00121	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000147	0.00121	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	0.000146	0.00121	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000145	0.0012	CbGpPWpGaD
Fluocinonide—Flunisolide—CYP3A4—type 2 diabetes mellitus	0.000144	0.0152	CrCbGaD
Fluocinonide—Paramethasone—CYP3A4—type 2 diabetes mellitus	0.000143	0.015	CrCbGaD
Fluocinonide—Ciclesonide—CYP3A4—type 2 diabetes mellitus	0.00014	0.0148	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000139	0.00115	CbGpPWpGaD
Fluocinonide—Fluorometholone—CYP3A4—type 2 diabetes mellitus	0.000139	0.0147	CrCbGaD
Fluocinonide—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	0.000134	0.0142	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000132	0.0011	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	0.000132	0.00109	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000131	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000131	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.00013	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000129	0.00107	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	0.000129	0.00107	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	0.000127	0.00105	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000127	0.00105	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000127	0.00105	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	0.000126	0.00105	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000126	0.00105	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000125	0.00103	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	0.000123	0.00102	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	0.000122	0.00101	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCC2—type 2 diabetes mellitus	0.000122	0.0129	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000122	0.00101	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	0.000121	0.001	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000121	0.001	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	0.00012	0.000996	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000117	0.000972	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000117	0.000972	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	0.000116	0.000961	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000116	0.000958	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000114	0.000945	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000114	0.000942	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000114	0.000941	CbGpPWpGaD
Fluocinonide—Triamcinolone—CYP3A4—type 2 diabetes mellitus	0.000113	0.0119	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000112	0.000925	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000111	0.000921	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000111	0.000921	CbGpPWpGaD
Fluocinonide—Triamcinolone—PTGS2—type 2 diabetes mellitus	0.000111	0.0117	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.00011	0.00091	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	0.000108	0.000897	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000107	0.000885	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000104	0.000857	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000102	0.000843	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000102	0.000843	CbGpPWpGaD
Fluocinonide—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	0.000101	0.0107	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.0001	0.000829	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.99e-05	0.000826	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL2—type 2 diabetes mellitus	9.53e-05	0.000789	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.36e-05	0.000775	CbGpPWpGaD
Fluocinonide—Dexamethasone—NR3C1—type 2 diabetes mellitus	9.32e-05	0.00982	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	9.3e-05	0.00077	CbGpPWpGaD
Fluocinonide—Betamethasone—CYP3A4—type 2 diabetes mellitus	9.29e-05	0.00979	CrCbGaD
Fluocinonide—Betamethasone—PTGS2—type 2 diabetes mellitus	9.09e-05	0.00958	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	9.07e-05	0.00075	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.86e-05	0.000733	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.78e-05	0.000726	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AVP—type 2 diabetes mellitus	8.66e-05	0.000716	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.66e-05	0.000716	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.62e-05	0.000713	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.58e-05	0.00071	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP2E1—type 2 diabetes mellitus	8.58e-05	0.00904	CrCbGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.49e-05	0.000703	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOB—type 2 diabetes mellitus	8.37e-05	0.000692	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.33e-05	0.00069	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.23e-05	0.000681	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	8.14e-05	0.000673	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	8.06e-05	0.000667	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LPL—type 2 diabetes mellitus	7.99e-05	0.000661	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	7.99e-05	0.000661	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.82e-05	0.000647	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	7.66e-05	0.000634	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	7.61e-05	0.00063	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	7.52e-05	0.000622	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.5e-05	0.00062	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	7.44e-05	0.000616	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	7.37e-05	0.00061	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.36e-05	0.000609	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	7.33e-05	0.000607	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—C3—type 2 diabetes mellitus	7.19e-05	0.000595	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	6.93e-05	0.000573	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	6.91e-05	0.000571	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.86e-05	0.000568	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	6.85e-05	0.000567	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.84e-05	0.000566	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGT—type 2 diabetes mellitus	6.84e-05	0.000566	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.72e-05	0.000556	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LEP—type 2 diabetes mellitus	6.7e-05	0.000554	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—type 2 diabetes mellitus	6.7e-05	0.000554	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.62e-05	0.000548	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.32e-05	0.000523	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.97e-05	0.000494	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.92e-05	0.00049	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—INS—type 2 diabetes mellitus	5.72e-05	0.000473	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	5.7e-05	0.000471	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.63e-05	0.000466	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.53e-05	0.000458	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.53e-05	0.000458	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	5.53e-05	0.000457	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.51e-05	0.000456	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP3A4—type 2 diabetes mellitus	5.4e-05	0.00569	CrCbGaD
Fluocinonide—Dexamethasone—PTGS2—type 2 diabetes mellitus	5.29e-05	0.00557	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.26e-05	0.000435	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	5.22e-05	0.000432	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.02e-05	0.000415	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.02e-05	0.000415	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.78e-05	0.000395	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RELA—type 2 diabetes mellitus	4.72e-05	0.000391	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	4.71e-05	0.00039	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	4.56e-05	0.000378	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	4.56e-05	0.000378	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	4.48e-05	0.000371	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.26e-05	0.000353	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	4.24e-05	0.000351	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.23e-05	0.00035	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.03e-05	0.000333	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.98e-05	0.00033	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.9e-05	0.000323	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	3.88e-05	0.000321	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SRC—type 2 diabetes mellitus	3.71e-05	0.000307	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	3.62e-05	0.000299	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.61e-05	0.000299	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	3.33e-05	0.000276	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.32e-05	0.000275	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	3.3e-05	0.000273	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.25e-05	0.000269	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	2.91e-05	0.000241	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	2.74e-05	0.000227	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—type 2 diabetes mellitus	2.5e-05	0.000207	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.31e-05	0.000191	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	2.27e-05	0.000188	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	2.04e-05	0.000169	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	8.96e-06	7.42e-05	CbGpPWpGaD
